Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Mar 18, 2008 7:58 am EDT

OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNA's, Including Its Phase III Compound Bevasiranib

Feb 25, 2008 9:18 am EST

OPKO Health and Pathogenics Announce Data Publication Demonstrating the Potential Utility of NCT in a Severe Eye Infection

Jan 25, 2008 9:15 am EST

OPKO Health Announces Changes to Board of Directors

Jan 23, 2008 8:00 am EST

OPKO Health to Present at 2008 Wachovia Healthcare Conference

Jan 14, 2008 8:00 am EST

OPKO Health Appoints Industry Veteran Dr. Naveed Shams as Chief Medical Officer

Dec 6, 2007 8:00 am EST

OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials

Dec 5, 2007 9:02 am EST

The Frost Group Invests $20 Million in OPKO Health

Nov 29, 2007 8:00 am EST

OPKO Health Completes Acquisition of Ophthalmic Technologies, Inc.

Oct 30, 2007 9:49 am EDT

OPKO Health Acquires Rights to Innovative Ocular Product to Prevent Serious Eye Infections

Oct 10, 2007 2:25 pm EDT

OPKO Health Acquires Rights to Clinical Stage Compound for Dry Eye